CYP2D6 is an enzyme that metabolizes many drugs, including some used for sleep (e.g., certain antidepressants, antipsychotics). A CYP2D6 genetic test can indicate whether someone is a poor or rapid metabolizer, affecting drug efficacy and side effects. However, CYP2D6 is not a direct 'sleep gene'. The evidence for using it to improve sleep is weak: no randomized trials show that CYP2D6-guided sleep medication adjustment leads to better sleep outcomes. Most data come from pharmacogenetics (mechanistic) rather than clinical endpoints. Moreover, sleep problems are multifactorial (stress, lifestyle, other genes). A standalone genetic test without medical supervision can lead to misinterpretation or inappropriate self-medication. Therefore: CYP2D6 is useful for sleep medication guidance, but not for sleep quality itself. Evidence is mixed – mechanistically plausible but clinically under-supported. Safety note: Do not change medications without a physician.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-44bb35c577c28074452dd974